RBC Capital analyst Ben Hendrix lowered the firm’s price target on CVS Health (CVS) to $58 from $68 and keeps an Outperform rating on the ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $68.4, with a high ...

At CVS Health, automation transcends mere enhancement; it is the strategic bedrock upon which the company rapidly meets ...

CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...

When we examine it carefully, culture can reveal the hidden barriers between current performance and desired success.

J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill covers the ...

Providing compassionate care isn't just a choice that health care workers make; it requires larger systems and leaders to ...

CVS Health Corp. faces continued challenges in its insurance business, prompting the company to shake up its management ranks in a bid to get back on track. Shares of the pharmacy and healthcare ...

Winners in 20 categories were honoured at the 2024 Community Volunteer Awards took at King George's Hall in Blackburn.

A former chief executive officer at UnitedHealthcare has been selected to serve as the president of CVS Health's Aetna insurance subsidiary. David Joyner, president and chief executive officer of CVS ...

Steve Nelson, a former chief executive officer of UnitedHealthcare, has been named the president of Hartford-based Aetna, ...

CVS Health today announced Prem Shah will be group president, and will continue to report to David Joyner, president and CEO. In addition, the company announced the appointment of Steve Nelson as ...